One (1) Cobas Liat Assays Analyzer, Associated PCR Kits, and Comprehensive Maintenance
Defense Health Agency · DEFENSE HEALTH AGENCY
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation PANDHA26P0000034421 in this department, oldest first.
- Jun 5, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
NOTICE OF INTENT TO SOLE SOURCE: This Notice of Intent is not a request for competitive proposals. This is not a solicitation or request for offers. No solicitation package is available, and telephone requests will not be honored. Only one responsible source, and no other supplies or services will satisfy agency requirements. The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) provides notice of its intent to award a firm-fixed-price, sole-source contract to Roche Diagnostics. This notice is not a request for competitive proposals; no solici… (show all)
tation package is available, and telephone requests will not be honored. The acquisition is conducted under the authority of Federal Acquisition Regulation (FAR) 6.302-1, "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements." Reference the attached Notice of Intent (NOI)
Who won similar work
3 award notices on SAM.gov in the last 24 months. Matched by: Same office (DEFENSE HEALTH AGENCY), same product/service code (PSC) Q301 and NAICS 621511.
Single-winner award sizes (3): middle half $1.8M to $3.7M, median $3.4M; range $328K to $4.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| BLOODWORKS Seattle WA 98104 USA | 1 | $4.0M | Oct 1, 2026 |
| SOPHIA GENETICS, INC. | 1 | $3.4M | Sep 26, 2025 |
| I-2-I Solutions, Inc. | 1 | $328K | Dec 10, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 1, 2026BLOODWORKS Seattle WA 98104 USA$4.0MBlood Donor Testing ServicesNo listed company matched (Materiality N/A)
- Dec 10, 2025I-2-I Solutions, Inc.$328KAward Water TestingNo listed company matched (Materiality N/A)
- Sep 26, 2025SOPHIA GENETICS, INC.$3.4MBioinformatics at Keesler Air Force BaseNo listed company matched (Materiality N/A)
Competitive landscape
For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (0 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.